Global Inosine Pranobex Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024


    Table of Contents

      1 Market Overview

      • 1.1 Inosine Pranobex Introduction
      • 1.2 Market Analysis by Type
        • 1.2.1 Tablet
        • 1.2.2 Syrup
      • 1.3 Market Analysis by Applications
        • 1.3.1 Immunomodulation
        • 1.3.2 Antiviral
        • 1.3.3 Other
      • 1.4 Market Analysis by Regions
        • 1.4.1 North America (United States, Canada and Mexico)
          • 1.4.1.1 United States Market States and Outlook (2014-2024)
          • 1.4.1.2 Canada Market States and Outlook (2014-2024)
          • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
        • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
          • 1.4.2.1 Germany Market States and Outlook (2014-2024)
          • 1.4.2.2 France Market States and Outlook (2014-2024)
          • 1.4.2.3 UK Market States and Outlook (2014-2024)
          • 1.4.2.4 Russia Market States and Outlook (2014-2024)
          • 1.4.2.5 Italy Market States and Outlook (2014-2024)
        • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
          • 1.4.3.1 China Market States and Outlook (2014-2024)
          • 1.4.3.2 Japan Market States and Outlook (2014-2024)
          • 1.4.3.3 Korea Market States and Outlook (2014-2024)
          • 1.4.3.4 India Market States and Outlook (2014-2024)
          • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
        • 1.4.4 South America, Middle East and Africa
          • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
          • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
          • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
          • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
          • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
      • 1.5 Market Dynamics
        • 1.5.1 Market Opportunities
        • 1.5.2 Market Risk
        • 1.5.3 Market Driving Force

      2 Manufacturers Profiles

      • 2.1 Newport Pharmaceuticals
        • 2.1.1 Business Overview
        • 2.1.2 Inosine Pranobex Type and Applications
          • 2.1.2.1 Product A
          • 2.1.2.2 Product B
        • 2.1.3 Newport Pharmaceuticals Inosine Pranobex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.2 Gedeon Richter
        • 2.2.1 Business Overview
        • 2.2.2 Inosine Pranobex Type and Applications
          • 2.2.2.1 Product A
          • 2.2.2.2 Product B
        • 2.2.3 Gedeon Richter Inosine Pranobex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.3 Mochida
        • 2.3.1 Business Overview
        • 2.3.2 Inosine Pranobex Type and Applications
          • 2.3.2.1 Product A
          • 2.3.2.2 Product B
        • 2.3.3 Mochida Inosine Pranobex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.4 Sanofi
        • 2.4.1 Business Overview
        • 2.4.2 Inosine Pranobex Type and Applications
          • 2.4.2.1 Product A
          • 2.4.2.2 Product B
        • 2.4.3 Sanofi Inosine Pranobex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.5 Andrómaco
        • 2.5.1 Business Overview
        • 2.5.2 Inosine Pranobex Type and Applications
          • 2.5.2.1 Product A
          • 2.5.2.2 Product B
        • 2.5.3 Andrómaco Inosine Pranobex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.6 Yung Shin
        • 2.6.1 Business Overview
        • 2.6.2 Inosine Pranobex Type and Applications
          • 2.6.2.1 Product A
          • 2.6.2.2 Product B
        • 2.6.3 Yung Shin Inosine Pranobex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.7 Sigma -Tau
        • 2.7.1 Business Overview
        • 2.7.2 Inosine Pranobex Type and Applications
          • 2.7.2.1 Product A
          • 2.7.2.2 Product B
        • 2.7.3 Sigma -Tau Inosine Pranobex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.8 Polfarmex
        • 2.8.1 Business Overview
        • 2.8.2 Inosine Pranobex Type and Applications
          • 2.8.2.1 Product A
          • 2.8.2.2 Product B
        • 2.8.3 Polfarmex Inosine Pranobex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.9 Sanfer
        • 2.9.1 Business Overview
        • 2.9.2 Inosine Pranobex Type and Applications
          • 2.9.2.1 Product A
          • 2.9.2.2 Product B
        • 2.9.3 Sanfer Inosine Pranobex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.10 Meprofarm
        • 2.10.1 Business Overview
        • 2.10.2 Inosine Pranobex Type and Applications
          • 2.10.2.1 Product A
          • 2.10.2.2 Product B
        • 2.10.3 Meprofarm Inosine Pranobex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.11 Novell Pharmaceutical
        • 2.11.1 Business Overview
        • 2.11.2 Inosine Pranobex Type and Applications
          • 2.11.2.1 Product A
          • 2.11.2.2 Product B
        • 2.11.3 Novell Pharmaceutical Inosine Pranobex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
      • 2.12 Aflofarm
        • 2.12.1 Business Overview
        • 2.12.2 Inosine Pranobex Type and Applications
          • 2.12.2.1 Product A
          • 2.12.2.2 Product B
        • 2.12.3 Aflofarm Inosine Pranobex Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

      3 Global Inosine Pranobex Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

      • 3.1 Global Inosine Pranobex Sales and Market Share by Manufacturer (2017-2018)
      • 3.2 Global Inosine Pranobex Revenue and Market Share by Manufacturer (2017-2018)
      • 3.3 Market Concentration Rate
        • 3.3.1 Top 3 Inosine Pranobex Manufacturer Market Share in 2018
        • 3.3.2 Top 6 Inosine Pranobex Manufacturer Market Share in 2018
      • 3.4 Market Competition Trend

      4 Global Inosine Pranobex Market Analysis by Regions

      • 4.1 Global Inosine Pranobex Sales, Revenue and Market Share by Regions
        • 4.1.1 Global Inosine Pranobex Sales and Market Share by Regions (2014-2019)
        • 4.1.2 Global Inosine Pranobex Revenue and Market Share by Regions (2014-2019)
      • 4.2 North America Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 4.3 Europe Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 4.4 Asia-Pacific Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 4.5 South America Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 4.6 Middle East and Africa Inosine Pranobex Sales and Growth Rate (2014-2019)

      5 North America Inosine Pranobex by Country

      • 5.1 North America Inosine Pranobex Sales, Revenue and Market Share by Country
        • 5.1.1 North America Inosine Pranobex Sales and Market Share by Country (2014-2019)
        • 5.1.2 North America Inosine Pranobex Revenue and Market Share by Country (2014-2019)
      • 5.2 United States Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 5.3 Canada Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 5.4 Mexico Inosine Pranobex Sales and Growth Rate (2014-2019)

      6 Europe Inosine Pranobex by Country

      • 6.1 Europe Inosine Pranobex Sales, Revenue and Market Share by Country
        • 6.1.1 Europe Inosine Pranobex Sales and Market Share by Country (2014-2019)
        • 6.1.2 Europe Inosine Pranobex Revenue and Market Share by Country (2014-2019)
      • 6.2 Germany Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 6.3 UK Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 6.4 France Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 6.5 Russia Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 6.6 Italy Inosine Pranobex Sales and Growth Rate (2014-2019)

      7 Asia-Pacific Inosine Pranobex by Country

      • 7.1 Asia-Pacific Inosine Pranobex Sales, Revenue and Market Share by Country
        • 7.1.1 Asia-Pacific Inosine Pranobex Sales and Market Share by Country (2014-2019)
        • 7.1.2 Asia-Pacific Inosine Pranobex Revenue and Market Share by Country (2014-2019)
      • 7.2 China Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 7.3 Japan Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 7.4 Korea Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 7.5 India Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 7.6 Southeast Asia Inosine Pranobex Sales and Growth Rate (2014-2019)

      8 South America Inosine Pranobex by Country

      • 8.1 South America Inosine Pranobex Sales, Revenue and Market Share by Country
        • 8.1.1 South America Inosine Pranobex Sales and Market Share by Country (2014-2019)
        • 8.1.2 South America Inosine Pranobex Revenue and Market Share by Country (2014-2019)
      • 8.2 Brazil Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 8.3 Argentina Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 8.4 Colombia Inosine Pranobex Sales and Growth Rate (2014-2019)

      9 Middle East and Africa Inosine Pranobex by Countries

      • 9.1 Middle East and Africa Inosine Pranobex Sales, Revenue and Market Share by Country
        • 9.1.1 Middle East and Africa Inosine Pranobex Sales and Market Share by Country (2014-2019)
        • 9.1.2 Middle East and Africa Inosine Pranobex Revenue and Market Share by Country (2014-2019)
      • 9.2 Saudi Arabia Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 9.3 Turkey Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 9.4 Egypt Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 9.5 Nigeria Inosine Pranobex Sales and Growth Rate (2014-2019)
      • 9.6 South Africa Inosine Pranobex Sales and Growth Rate (2014-2019)

      10 Global Inosine Pranobex Market Segment by Type

      • 10.1 Global Inosine Pranobex Sales, Revenue and Market Share by Type (2014-2019)
        • 10.1.1 Global Inosine Pranobex Sales and Market Share by Type (2014-2019)
        • 10.1.2 Global Inosine Pranobex Revenue and Market Share by Type (2014-2019)
      • 10.2 Tablet Sales Growth and Price
        • 10.2.1 Global Tablet Sales Growth (2014-2019)
        • 10.2.2 Global Tablet Price (2014-2019)
      • 10.3 Syrup Sales Growth and Price
        • 10.3.1 Global Syrup Sales Growth (2014-2019)
        • 10.3.2 Global Syrup Price (2014-2019)

      11 Global Inosine Pranobex Market Segment by Application

      • 11.1 Global Inosine Pranobex Sales Market Share by Application (2014-2019)
      • 11.2 Immunomodulation Sales Growth (2014-2019)
      • 11.3 Antiviral Sales Growth (2014-2019)
      • 11.4 Other Sales Growth (2014-2019)

      12 Inosine Pranobex Market Forecast (2019-2024)

      • 12.1 Global Inosine Pranobex Sales, Revenue and Growth Rate (2019-2024)
      • 12.2 Inosine Pranobex Market Forecast by Regions (2019-2024)
        • 12.2.1 North America Inosine Pranobex Market Forecast (2019-2024)
        • 12.2.2 Europe Inosine Pranobex Market Forecast (2019-2024)
        • 12.2.3 Asia-Pacific Inosine Pranobex Market Forecast (2019-2024)
        • 12.2.4 South America Inosine Pranobex Market Forecast (2019-2024)
        • 12.2.5 Middle East and Africa Inosine Pranobex Market Forecast (2019-2024)
      • 12.3 Inosine Pranobex Market Forecast by Type (2019-2024)
        • 12.3.1 Global Inosine Pranobex Sales Forecast by Type (2019-2024)
        • 12.3.2 Global Inosine Pranobex Market Share Forecast by Type (2019-2024)
      • 12.4 Inosine Pranobex Market Forecast by Application (2019-2024)
        • 12.4.1 Global Inosine Pranobex Sales Forecast by Application (2019-2024)
        • 12.4.2 Global Inosine Pranobex Market Share Forecast by Application (2019-2024)

      13 Sales Channel, Distributors, Traders and Dealers

      • 13.1 Sales Channel
        • 13.1.1 Direct Marketing
        • 13.1.2 Indirect Marketing
        • 13.1.3 Marketing Channel Future Trend
      • 13.2 Distributors, Traders and Dealers

      14 Research Findings and Conclusion

        15 Appendix

        • 15.1 Methodology

        Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.

        Scope of the Report:
        The classification of Inosine Pranobex includes Tablet, Syrup, the sales of Tablet are 8.45 million units, with its market share 69.3%. And the sales market share of Syrup is 30.7% in 2017.
        Inosine Pranobex is widely used to treat Immunomodulation, Antiviral and Other. The most proportion of Inosine Pranobex is to treat Antiviral, and the proportion is about 48.6% in 2017.
        Europe region is the largest supplier of Inosine Pranobex, with a production market share nearly 57% in 2017. North America is the second largest supplier of Inosine Pranobex, enjoying revenue market share nearly 8.7% in 2017.
        The worldwide market for Inosine Pranobex is expected to grow at a CAGR of roughly 1.9% over the next five years, will reach 210 million US$ in 2024, from 180 million US$ in 2019, according to a new GIR (Global Info Research) study.
        This report focuses on the Inosine Pranobex in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

        Market Segment by Manufacturers, this report covers
        Newport Pharmaceuticals
        Gedeon Richter
        Mochida
        Sanofi 
        Andrómaco
        Yung Shin
        Sigma -Tau
        Polfarmex
        Sanfer
        Meprofarm
        Novell Pharmaceutical
        Aflofarm

        Market Segment by Regions, regional analysis covers
        North America (United States, Canada and Mexico)
        Europe (Germany, France, UK, Russia and Italy)
        Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        South America (Brazil, Argentina, Colombia etc.)
        Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

        Market Segment by Type, covers
        Tablet
        Syrup

        Market Segment by Applications, can be divided into
        Immunomodulation
        Antiviral
        Other

        The content of the study subjects, includes a total of 15 chapters:
        Chapter 1, to describe Inosine Pranobex product scope, market overview, market opportunities, market driving force and market risks.
        Chapter 2, to profile the top manufacturers of Inosine Pranobex, with price, sales, revenue and global market share of Inosine Pranobex in 2017 and 2018.
        Chapter 3, the Inosine Pranobex competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
        Chapter 4, the Inosine Pranobex breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
        Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
        Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
        Chapter 12, Inosine Pranobex market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
        Chapter 13, 14 and 15, to describe Inosine Pranobex sales channel, distributors, customers, research findings and conclusion, appendix and data source.



        Summary:
        Inosine Pranobex Market Research Report is Inosine Pranobex Market Report. Get Inosine Pranobex market research reports for Market Research, Analysis, Trends & Statistics. Latest Industry findings, analysis and Market Report on Inosine Pranobex. Inosine Pranobex Market Report is a syndicated market report to understand, Market Demand, Growth, trends analysis and Factor Influencing market in upcoming years.



        REPORT YOU MIGHT BE INTERESTED